Saltar al contenido
Merck

Inflammasome activation is critical to the protective immune response during chemically induced squamous cell carcinoma.

PloS one (2014-10-01)
Thais Helena Gasparoto, Carine Ervolino de Oliveira, Luisa Thomazini de Freitas, Claudia Ramos Pinheiro, Juliana Issa Hori, Gustavo Pompermaier Garlet, Karen Angélica Cavassani, Roxana Schillaci, João Santana da Silva, Dario Simões Zamboni, Ana Paula Campanelli
RESUMEN

Chronic inflammation affects most stages of tumorigenesis, including initiation, promotion, malignant differentiation, invasion and metastasis. Inflammasomes have been described as involved with persistent inflammation and are known to exert both pro and antitumour effects. We evaluated the influence of apoptosis-associated speck-like protein containing a caspase recruitment domain (ASC) and caspase (CASP)-1 in the antitumor immune response using a multistage model of squamous cell carcinoma (SCC) development. Absence of ASC and CASP-1 resulted in an earlier incidence and increased number of papilloma. Loss of inflammassome function in mice resulted in decreased presence of natural killer (NK), dendritic (DC), CD4(+), CD8(+) and CD45RB(+) T cells in the tumor lesions as well as in lymph nodes (LN) compared with WT mice. Increased percentage of CD4(+)CD25(+)Foxp3(+) T cells was associated with association with inflammasome loss of function. Moreover, significant differences were also found with neutrophils and macrophage infiltrating the lesions. Myeloperoxidase (MPO), but not elastase (ELA), activity oscillated among the groups during the SCC development. Levels of proinflammatory cytokines IL-1β, IL-18, Tumor Necrosis Factor (TNF)-α and Interferon (IFN)-γ were decreased in the tumor microenvironment in the absence of inflammasome proteins. These observations suggest a link between inflammasome function and SCC tumorigenesis, indicating an important role for inflammasome activation in the control of SCC development.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, ACS reagent
Sigma-Aldrich
Peróxido de hidrógeno solution, 30 % (w/w) in H2O, contains stabilizer
Sigma-Aldrich
Acida sódica, ReagentPlus®, ≥99.5%
Sigma-Aldrich
Peróxido de hidrógeno solution, 50 wt. % in H2O, stabilized
Sigma-Aldrich
Acida sódica, BioUltra, ≥99.5% (T)
Millipore
Peróxido de hidrógeno solution, 3%, suitable for microbiology
Supelco
Peróxido de hidrógeno solution, ≥30%, for trace analysis
Sigma-Aldrich
Acida sódica, purum p.a., ≥99.0% (T)
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 35 wt. % in H2O
Sigma-Aldrich
Acida sódica, BioXtra
Sigma-Aldrich
Peróxido de hidrógeno solution, 34.5-36.5%
Supelco
Peróxido de hidrógeno solution, 30 % (w/w), for ultratrace analysis
Sigma-Aldrich
Peróxido de hidrógeno solution, contains inhibitor, 30 wt. % in H2O, meets USP testing specifications
Sigma-Aldrich
Peróxido de hidrógeno solution, tested according to Ph. Eur.
Sigma-Aldrich
Human IL18 / Interleukin-18 ELISA Kit, for serum, plasma, cell culture supernatants and urine
Sigma-Aldrich
Mouse Il18 / Interleukin-18 ELISA Kit, for serum, plasma and cell culture supernatants